Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer

Lemur tail kinase 3 (LMTK3) belongs to a family of tyrosine kinases that are known to correlate with tumor grade and patient survival in some cancers. Here, we validated LMTK3 as a specific target and a prognostic biomarker in ovarian cancer (OC). In samples from 204 stage I–II OC patients, immunohi...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ghassan M. Saed, Nicole M. Fletcher, Harvey Sharma, Axel Stenmark Tullberg, Ella Ittner, Toshima Z. Parris, Daniella Pettersson, Anikó Kovács, Elisabeth Werner Rönnerman, Pernilla Dahm-Kähler, Anna Portela, Pamela D. Garzone, Robert Morris, Khalil Helou
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2024-09-01
Saila:	Molecular Therapy: Oncology
Gaiak:	binding peptides chemoresistance lemur tail kinase 3 ovarian cancer targeted therapy
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2950329924001061
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!